Motherbase – Diotheris

Entity

Diotheris

Created in 2020
BETA

Probably non active (C)
Several signals show that this company is not active anymore
Social networks
230
Activities

deeptech biotech healthtech
Technologies

Synthetic Biology
Entity types

Startup
Location

Paris, France

Paris

France
Employees

Scale: 2-10

Estimated: 1
Engaged corporates
1
1 0
Added in Motherbase
10 months ago

Description

Value proposition

Diotheris develops anti-infective microbes to prevent bacterial infections and act against antibiotic resistance

We create bacterial therapies of the human skin and mucosal microbiome against pathogenic bacteria. Our first suite of products (NASOFLORE line) targets Staphyloccocus aureus / MRSA (Methicillin resistant S aureus). The products based on live bacteria identified in our clinical and in vitro studies do not generate emergence of antibiotic resistance.

antimicrobial, nose microbiome, therapeutics, LBP, Staphylococcus Aureus, and MRSA
Original language

Diotheris develops anti-infective microbes to prevent bacterial infections and act against antibiotic resistance

We create bacterial therapies of the human skin and mucosal microbiome against pathogenic bacteria. Our first suite of products (NASOFLORE line) targets Staphyloccocus aureus / MRSA (Methicillin resistant S aureus). The products based on live bacteria identified in our clinical and in vitro studies do not generate emergence of antibiotic resistance.

diotheris.com

Ce domaine a été enregistré chez Gandi.net. Le propriétaire de ce domaine n'a pas encore activé de site web.

Corporate interactions BETA

Corporate		Type	Tweets	Articles
SATT Paris-Saclay Research, Startup accelerator & VC, Research Services	SATT Paris-Saclay Research, Startup accelerator & VC, Research Services	Other 7 Jan 2023		7 Jan 2023

Similar entities

Last news

Social network dynamics